Drreddys Laboratories | RDY - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
ANI Pharmaceuticals USD 73.66M 9.14M 2026-03
Aurora Cannabis CAD 41.4M 781K 2026-03
Bayer EUR 3.7B 356M 2026-03
Canopy Growth CAD 31.17M 2.27M 2026-03
Cipla INR 13.25B 101.8M 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Drreddys Laboratories INR 14.47B 12.45B 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Novartis USD 3.14B 296M 2026-03
Pacira USD 83.88M 7.99M 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 30.28M 606K 2026-03
Richter Gedeon HUF 55.32B 3.03B 2026-03
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Teva Pharmaceutical Industries USD 1000M 120M 2026-03